Home > Boards > US Listed > Biotechs > Cytori Therapeutics, Inc. (CYTX)

NEWS -- Cytori Reports Fourth Quarter and Full

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Paulness Member Profile
 
Followed By 64
Posts 9,994
Boards Moderated 0
Alias Born 11/02/03
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 6:41:20 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/7/2019 6:25:28 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/3/2019 4:43:30 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/27/2019 11:18:48 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 9/24/2019 4:07:28 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/24/2019 6:00:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2019 5:21:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2019 6:35:17 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 9/16/2019 4:08:45 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/16/2019 4:04:06 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/10/2019 7:24:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 6:22:47 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/26/2019 4:08:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/21/2019 8:01:33 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/15/2019 5:32:08 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2019 5:10:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 4:33:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 8:00:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 4:05:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 8:01:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2019 8:01:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2019 4:51:16 PM
Cytori Will Become Plus Therapeutics, Inc. GlobeNewswire Inc. - 7/16/2019 4:15:00 PM
Cytori to Present Corporate Update & New Strategic Direction GlobeNewswire Inc. - 7/11/2019 8:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2019 5:26:24 PM
Paulness   Monday, 04/01/19 09:06:27 AM
Re: None
Post # of 2710 
NEWS -- Cytori Reports Fourth Quarter and Full Year 2018 Business and Financial Results
  • Strategic focus on building a leading oncology company / Lorem Vascular cell therapy transaction yields $4MM
  • Letter of intent for ATI-0918 filed with EMEA
SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (CYTX) (“Cytori” or the “Company”) today announced its fourth quarter and year-end 2018 financial results and provided updates on corporate activities. Also announced was a transaction to divest certain cell therapy assets to Lorem Vascular of Melbourne, Australia yielding $4MM in non-dilutive funding to the Company.

Fourth quarter 2018 net loss was $2.2 million, or $0.16 per share. Operating cash burn for the fourth quarter of 2018 was approximately $2.5 million. Cytori ended the year with approximately $5.3 million of cash and cash equivalents.

The Full Press Release can be found here:

https://finance.yahoo.com/news/cytori-reports-fourth-quarter-full-120500623.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist